Oncology VenturesFounder and Managing Partner
Until PresentNew York, NY
Invests in commercially validated startups across the cancer care journey, from early detection to survivorship. Writes the Oncology Ventures newsletter on Substack.
3 unread notifications
Ben Freeberg founded Oncology Ventures, a firm investing in commercially validated startups transforming cancer care. Following their $32M Fund II, in 2026 announced its oversubscribed $62M Fund II. A cancer survivor and stand-up comic, he previously invested in healthcare technology at Optum Ventures and Alpha Partners and helped build Thyme Care, a value-based cancer care company.
Ben Freeberg founded Oncology Ventures, a firm investing in commercially validated startups transforming cancer care. Following their $32M Fund II, in 2026 announced its oversubscribed $62M Fund II. A cancer survivor and stand-up comic, he previously invested in healthcare technology at Optum Ventures and Alpha Partners and helped build Thyme Care, a value-based cancer care company.
Career
Thyme CareDirector of Growth
Oct 2021 — Nov 2022
Solomon PartnersInvestment Banking Analyst
2015 — 2016
Susquehanna Growth Equity (SGE)Private Equity Analyst
2014 — 2014
CED (Center for Entrepreneurial Development)Marketing and Consulting Intern
2012 — 2012
Cosigns Received
Featured Media
oncologyventures.substack.com
Announcing Oversubscribed $62M Fund II to Accelerate the Future of Cancer Care
oncologyventures.substack.com
Cancer Care in 2040
oncologyventures.substack.com
A Working Playbook for Funding Cancer Innovation
oncologyventures.substack.com
What if Cancer Care Operated Like The Ritz-Carlton
